...
【24h】

The Role of Central mu Opioid Receptors in Opioid-lnduced Itch in Primates

机译:中枢阿片类药物受体在灵长类动物阿片类药物引起的瘙痒中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Pruritus (itch sensation) is a significant clinical problem.The aim of this study was to elucidate the roles of opioid receptor types and the site of action in opioid-induced itch in monkeys.Observers who were blinded to the conditions counted scratching after administration of various drugs.Intravenous (i.v.) administration of mu opioid receptor (MOR) agonists (fentanyl,alfen-tanil,remifentanil,and morphine) evoked scratching in a dose-and time-dependent manner.However,the kappa opioid agonist U-50488H [trans-(+-)-3,4-dichloro-N-methyl-N-(2-[1 -pyrro-lidinyl]-cyclohexyl)-benzeneacetamide] and 8 opioid agonist SNC80 [(+)-4-[(alphaR)-alpha-[2S,5R)-4-allyl-2,5-dimethyl-1 -pipera-zinyl]-3-methoxybenzyl]-N,N-diethylbenzamide] did not increase scratching.Intrathecal (i.t.) administration of peptidic MOR agonist [D-Ala~2,N-Me-Phe~4,Gly~5-ol]-enkephalin (DAMGO,0.00032-0.01 mg) evoked scratching,but i.v.DAMGO (0.01-1 mg/kg) did not increase scratching.A similar difference between i.t.and i.v.effectiveness was seen with morphine.Antagonist studies revealed that i.v.administration of an opioid receptor antagonist (naltrexone,0.0032-0.1 mg/kg) dose dependently attenuated scratching induced by i.v.fentanyl (0.018 mg/kg) or morphine (1 mg/kg).However,a peripherally,selective opioid antagonist (quaternary naltrexone,0.0032-0.32 mg/kg) did not block i.v.fentanyl- or morphine-induced scratching.Moreover,a hista-mine antagonist (diphenhydramine,0.1-10 mg/kg),failed to attenuate scratching induced by i.t.morphine (0.032 mg) or i.v.morphine (1 mg/kg).Pretreatment with a selective MOR antagonist (clocinnamox,0.1 mg/kg),but not kappa or delta opioid antagonists (nor-binaltorphimine or naltrindole),blocked i.t.morphine-induced scratching.Together,these data suggest that MOR,not other opioid receptor types or histamine,mediates scratching evoked by opioid analgesics.More important,this study provides in vivo pharmacological evidence that activation of central MOR plays an important role in opioid-induced itch in primates.
机译:瘙痒(瘙痒感)是一个重要的临床问题,本研究旨在阐明阿片类药物受体类型的作用以及阿片类药物引起的瘙痒在猴子中的作用。静脉内(iv)施用mu阿片受体(MOR)激动剂(芬太尼,alfen-tanil,remifentanil和吗啡)引起剂量和时间依赖性。但是,κ阿片激动剂U-50488H [反式(+-)-3,4-二氯-N-甲基-N-(2- [1-吡咯烷基]-环己基)-苯乙酰胺]和8阿片类激动剂SNC80 [(+)-4-[[alphaR )-α-[2S,5R)-4-烯丙基-2,5-二甲基-1-哌嗪基] -3-甲氧基苄基] -N,N-二乙基苯甲酰胺]没有增加挠性。鞘内注射肽MOR激动剂[D-Ala〜2,N-Me-Phe〜4,Gly〜5-ol]-脑啡肽(DAMGO,0.00032-0.01 mg)引起抓挠,但ivDAMGO(0.01-1 mg / kg)没有增加抓挠.it和ive之间的类似区别拮抗剂研究表明,阿片类药物受体拮抗剂(纳曲酮,0.0032-0.1 mg / kg)的静脉给药剂量依赖性地减轻了由艾芬太尼(0.018 mg / kg)或吗啡(1 mg / kg)引起的刮擦。然而,外围的选择性阿片拮抗剂(季纳曲酮,0.0032-0.32 mg / kg)没有阻止ivfentanyl-或吗啡诱导的抓挠。此外,组胺拮抗剂(苯海拉明,0.1-10 mg / kg)失败。减轻由吗啡(0.032 mg)或iv吗啡(1 mg / kg)引起的刮擦。用选择性MOR拮抗剂(clocinnamox,0.1 mg / kg)进行预处理,但不对kappa或delta阿片类拮抗剂(去甲双萘酚或纳曲通)进行预处理,这些数据表明,MOR,而不是其他阿片受体类型或组胺,介导阿片类镇痛药引起的刮擦。更重要的是,这项研究提供了体内药理学证据,证明中枢MOR的激活起着重要作用一世阿片类药物引起的灵长类动物瘙痒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号